Wedbush Securities Inc Adamis Pharmaceuticals Corp Transaction History

Wedbush Securities Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 16, 2020	SELL	$0.51 - $1.26 $44,166 - $109,116	-86,600 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$0.7 - $1.46 $29,399 - $61,320	42,000 Added 94.17%	86,600 $61,000
Q2 2019 Aug 01, 2019	BUY	$1.26 - $2.23 $32,760 - $57,980	26,000 Added 139.78%	44,600 $58,000
Q1 2019 Apr 17, 2019	BUY	$2.02 - $3.22 $37,572 - $59,892	18,600 New	18,600 $39,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.